期刊
ANALYTICAL CHEMISTRY
卷 93, 期 32, 页码 11275-11283出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.1c02264
关键词
-
资金
- National Natural Science Foundation of China [22074112]
- Fundamental Research Funds for the Central Universities [2042018kf1006]
Accurate diagnosis and targeted therapy are important for precision theranostics. This study presents an activatable DNA nanosphere for specific sensing of cancer biomarker FEN1 and modulating drug release, showing good stability, sensitivity, and specificity, providing a reliable method for FEN1 imaging and suggesting a powerful strategy for precision medicine.
Accurate diagnosis and targeted therapy are essential to precision theranostics. However, nonspecific response of theranostic agents in healthy tissues impedes their practical applications. Here, we design an activatable DNA nanosphere for specifically in situ sensing of cancer biomarker flap endonuclease 1 (FEN1) and spatiotemporally modulating drug release. The gold nanostar-conjugated FEN1 substrate acts as spherical nucleic acid and induces a fluorescence signal upon a FEN1 stimulus for diagnosis. Guided by the nanoflare, external NIR light then triggers a controlled release of carried drugs at desired sites. This DNA nanosphere not only exhibits good stability, sensitivity, and specificity toward FEN1 assay but also serves as a precision theranostic agent for targeted and controlled drug delivery. Our study provides a reliable method for FEN1 imaging in vitro and in vivo and suggests a powerful strategy for precision medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据